达托霉素负载脂质纳米载体通过膜介导协同杀灭MRSA
该研究开发了负载达托霉素的脂质立方体纳米载体,在体外对14株临床MRSA分离株表现出优于单用达托霉素或空载体的协同杀菌作用,机制涉及载体锚定细菌表面释放药物并融合入膜。在小鼠败血症模型中,负载达托霉素的立方体显著降低器官细菌负荷。
要点
- 负载达托霉素的脂质立方体对14株临床MRSA分离株体外协同杀菌。
- 协同机制为立方体锚定细菌表面释放达托霉素并融合入膜。
- 小鼠败血症模型中负载达托霉素立方体显著降低器官细菌负荷。
核心结论
- 负载达托霉素的脂质立方体纳米载体可通过膜靶向特洛伊木马样机制增强达托霉素对MRSA的杀菌活性。
研究设计与样本
- 体外研究使用14株临床MRSA分离株比较负载达托霉素立方体与单用达托霉素或空立方体的杀菌效果。
- 体内研究采用小鼠败血症模型评估负载达托霉素立方体对器官细菌负荷的影响。
主要发现
- 负载达托霉素的立方体在体外对14株临床MRSA分离株表现出协同杀菌作用,优于单用达托霉素或空立方体。
- 协同作用由立方体锚定于金黄色葡萄球菌细胞表面、释放达托霉素进行膜提取和穿透、随后脂质立方体融入细菌膜所介导。
- 在小鼠败血症模型中,负载达托霉素的立方体显著降低MRSA的器官细菌负荷。
临床怎么用
- 该纳米载体策略可能为增强达托霉素对MRSA的杀菌效果提供新思路,但尚未进入临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preservation and augmentation of existing antimicrobials is crucial in combating antimicrobial resistance. Gram-positive bacteria, exemplified by Staphylococcus aureus, are among the most common human bacterial pathogens, with methicillin-resistant S. aureus (MRSA) now established globally. Daptomycin is a last-line anti-staphylococcal antimicrobial that uniquely targets the bacterial membrane with bactericidal effects. Here, we developed lipid-based nanoparticles, namely cubosomes, to encapsulate daptomycin for targeted delivery via lipid-mediated interactions. Daptomycin-loaded cubosomes synergistically killed 14 clinical MRSA isolates in vitro compared with daptomycin or cubosomes alone. This synergy between daptomycin and cubosome was mediated by cubosomes docking on the S. aureus cell surface, releasing daptomycin for membrane extraction and penetration, followed by lipid cubosome infusion into S. aureus membranes. Using a murine septicemia model, daptomycin-loaded cubosomes significantly reduced the organ bacterial burden of MRSA. Together, these data showed that multifunctional lipid nanocarriers can potentiate the bactericidal activity of daptomycin using a membrane-targeted trojan-horse-like mechanism.
引用
- Jiang JH, Lim CX, Lai X, et al. Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting. J Infect Dis. 2026. PMID: 41189495. doi:10.1093/infdis/jiaf492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。